DiscGenics (Salt Lake City, UT) has treated the first patient in its Phase 3 clinical trial of IDCT, a cell-based therapy targeting lumbar degenerative disc disease, marking a key regulatory and clinical milestone.
by Mark Tullis
Tech News
-
Jan 12, 2026
The Office That Puts Humans Back in Control of the Machine
by Stevie Ibarra